Sort
261,768 grants matching “gene therapy”
High-throughput development and characterization of compact tools for transcriptional and chromatin perturbations
$992,590Lacramioara Bintu · Stanford University · R01 · FY2023 · HG
Bio-Therapies for the Treatment of Cancer and Infectious Disease
$992,485David Fitzgerald · Basic Sciences · Z01 · FY2007 · CA
Heritable Disorders Of Connective Tissue
$992,482Joan C Marini · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
Bay Area Cancer Target Discovery and Development
$992,465Michael T McManus · University Of California, San Francisco · U01 · FY2025 · CA
Immunomodulatory AVM0703 to bridge Relapsed/Refractory Diffuse Large B-Cell Lymphoma patients to CAR-T cell immunotherapy
$992,425Theresa Deisher · Avm Biotechnology, Llc · R44 · FY2025 · CA
High-throughput development and characterization of compact tools for transcriptional and chromatin perturbations
$992,388Lacramioara Bintu · Stanford University · R01 · FY2021 · HG
An Inhaled Microbiome-Targeted Biotherapeutic for Treatment of COPD
$992,385Teodora Nicola · Alveolus Bio, Inc. · R44 · FY2025 · HL
CTC Purification System Based on Thermoresponsive NanoSubstrates
$992,352Sean Xiao Liu · Cytolumina Technologies Corporation, Inc · R44 · FY2015 · CA
CTC Purification System Based on Thermoresponsive NanoSubstrates
$992,352Sean Xiao Liu · Cytolumina Technologies Corporation, Inc · R44 · FY2016 · CA
Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (AD)
$992,308Paul B Rosenberg · Johns Hopkins University · R01 · FY2021 · AG
InflammaGut: a drug-screenable co-culture system using gut-associated lymphocytes and autologous primary human gut epithelium that reports inflammation
$992,302Bill Thelin · Altis Biosystems, Inc. · R44 · FY2022 · TR
Institute of Human Virology Clinical Trials Unit
$992,201William Albert Blattner · University Of Maryland Baltimore · U01 · FY2008 · AI
Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery
$992,188Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2024 · CA
A Solid-Phase, Long-Acting CCR5 Monoclonal Antibody for HIV Transmission
$992,151Jonah B. Sacha · Oregon Health & Science University · R01 · FY2024 · AI
Northwestern University O'Brien Kidney National Resource Center
$992,052Susan E Quaggin · Northwestern University At Chicago · U54 · FY2023 · DK
Agonists of the RIG-I Innate Immune Pathway
$992,047Shawn Patrick Iadonato · Kineta, Inc. · R44 · FY2011 · AI
RECOMBINANT AAV FOR CORRECTION OF GENETIC ABNORMALITIES
$992,040University Of Florida · P01 · FY2002 · DK
Extracellular non-coding RNA biomarkers of hepatocellular cancer
$991,993Tushar Patel · Mayo Clinic Jacksonville · UH3 · FY2015 · TR
Novel Plasmodial Surface Anion Channel Inhibitors as Antimalarial Drugs
$991,947Michelle M. Butler · Microbiotix, Inc · R44 · FY2020 · AI
PATHOGENESIS AND PREVENTION OF OSTEOPOROSIS
$991,902University Of Connecticut Sch Of Med/Dnt · P01 · FY2000 · AR
Role of IgG Fc Glycan Composition in Vaccination
$991,876Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2018 · AI
Targeting the checkpoint regulator VISTA for treatment of inflammatory disease
$991,804Jay L Rothstein · Immunext, Inc. · R44 · FY2017 · AI
Studies of Receptor Interactions and Effects of Alarmins
$991,767Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
SDMC: HIV Vaccine Trials Network
$991,756Peter B. Gilbert · Fred Hutchinson Cancer Center · UM1 · FY2025 · AI
Severe Chronic Neutropenia International Registry
$991,744David Chandler Dale · University Of Washington · R24 · FY2015 · AI